Astromech, an AI biological data spinout from Colossal Biosciences, raised $10.5 million in a seed extension, bringing the round to $40.5 million, co-founder and CEO Ben Lamm tells Axios Pro.
Why it matters: Astromech joins a small wave of startups emerging from Dallas-based Colossal, including computational life sciences platform Form Bio.
